Skip to main content
Top
Published in: International Urology and Nephrology 4/2005

01-12-2005 | Case Report

Case Report: Octreotide as an Adjunct to Embolisation in the Management of Recurrent Bleeding Upper Gastrointestinal Metastases from Primary Renal Cell Cancer

Authors: Gavin W. A. Lamb, Jon Moss, Richard Edwards, Michael Aitchison

Published in: International Urology and Nephrology | Issue 4/2005

Login to get access
Metadata
Title
Case Report: Octreotide as an Adjunct to Embolisation in the Management of Recurrent Bleeding Upper Gastrointestinal Metastases from Primary Renal Cell Cancer
Authors
Gavin W. A. Lamb
Jon Moss
Richard Edwards
Michael Aitchison
Publication date
01-12-2005
Publisher
Kluwer Academic Publishers
Published in
International Urology and Nephrology / Issue 4/2005
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-005-0251-z

Other articles of this Issue 4/2005

International Urology and Nephrology 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine